Related references
Note: Only part of the references are listed.Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou et al.
CELL (2021)
Genomic Characterization of a Novel SARS-CoV-2 Lineage from Rio de Janeiro, Brazil
Carolina M. Voloch et al.
JOURNAL OF VIROLOGY (2021)
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally et al.
NATURE (2021)
The effect of spike mutations on SARS-CoV-2 neutralization
Chloe Rees-Spear et al.
CELL REPORTS (2021)
A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples
Taruna Madan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)
Evaluation of recombinant human SP-D in the rat premature lung model
Raquel Arroyo et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2021)
Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles
Miao-Hsi Hsieh et al.
FRONTIERS IN IMMUNOLOGY (2021)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structure and activity of human surfactant protein D from different natural sources
Raquel Arroyo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
Matt Arentz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe et al.
SCIENCE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Functional characterization of the different oligomeric forms of human surfactant protein SP-D
Raquel Arroyo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
Neutrophil extracelluar traps in COVID-19
Yu Zuo et al.
JCI INSIGHT (2020)
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome
Laura Pandolfi et al.
BMC PULMONARY MEDICINE (2020)
SP-D attenuates LPS-induced formation of human neutrophil extracellular traps (NETs), protecting pulmonary surfactant inactivation by NETs
Raquel Arroyo et al.
COMMUNICATIONS BIOLOGY (2019)
Supramolecular Assembly of Human Pulmonary Surfactant Protein SP-D
R. Arroyo et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Surfactant Protein D Deficiency Increases Lung Injury during Endotoxemia
Brooke A. King et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD
Carla Winkler et al.
RESPIRATORY RESEARCH (2011)
Surfactant Protein-D Inhibits Lung Inflammation Caused by Ventilation in Premature Newborn Lambs
Atsuyasu Sato et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Pulmonary Surfactant Protein D Inhibits Lipopolysaccharide (LPS)-induced Inflammatory Cell Responses by Altering LPS Binding to Its Receptors
Masami Yamazoe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Surfactant protein-d and surfactant inhibit endotoxin-induced pulmonary inflmmation
Machiko Ikegami et al.
CHEST (2007)
Surfactant protein A and surfactant protein D variation in pulmonary disease
Grith Lykke Sorensen et al.
IMMUNOBIOLOGY (2007)
The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages
Rikke Leth-Larsen et al.
IMMUNOBIOLOGY (2007)
Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D
Paul S. Kingma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human pulmonary surfactant protein D binds the extracellular domains of toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide
Madoka Ohya et al.
BIOCHEMISTRY (2006)
Intratracheal recombinant surfactant protein D prevents endotoxin shock in the newborn preterm lamb
M Ikegami et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
In defense of the lung: surfactant protein A and surfactant protein D
PS Kingma et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Immunoregulatory functions of surfactant proteins
JR Wright
NATURE REVIEWS IMMUNOLOGY (2005)
Surfactant protein-D enhances phagocytosis and pulmonary clearance of respiratory syncytial virus
AM LeVine et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2004)
By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation
SJ Gardai et al.
CELL (2003)
Surfactant protein D enhances clearance of influenza A virus from the lung in vivo
AM LeVine et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
